The whole human proteome may be free to browse thanks to DeepMind, but at the bleeding edge of biotech new proteins are made and tested every day, a complex and time-consuming process. Glyphic Biotechnologies accelerates the critical but slow sequencing step, potentially cutting drug development times down by a huge amount, and the startup just raised a $6M seed to bring its clever solution to market.

https://techcrunch.com/2021/07/26/glyphic-biotechnologies-raises-6m-to-accelerate-protein-sequencing-by-orders-of-magnitude/